Navigating Risk and Uncertainty

Uncovering undervalued investment opportunities, and thinking through risk, uncertainty and the pursuit of truth.

October Commendations: Placed Sixth Among Analysts on SumZero

I have once again been recognised in the SumZero rankings, ranking #6 globally (LTM) among 16,000+ buy-side professionals. My 18 featured investments have generated ~16% average total return, outperforming the S&P 500 by +11% and compounding into an...

Genomic Ambitions, Financial Realities: A Sell Thesis on Caris Life Sciences

Position closed on 6 Oct. 2025 at a price of $31.78, with a return of 6.7%. Caris Life Sciences, Inc. (CAI: $34.21 per share) positions itself as a future leader in precision medicine, but the odds are firmly against it. The company faces an...

Apex Mining and The Second Gilded Age

Closed position on 27 October, 2025, with a 14.4% return, and then re-opened the position on 17 December, 2025. Gold mining has historically been a poor way to capture gold’s value, with overinvestment, low-quality assets, and poor capital discipline...

#7 Ranked Analyst By SumZero

My investment methodology and risk philosophy has earned me the #7 ranking on SumZero for the last twelve months. SumZero is a highly exclusive buy-side only platform that connects capital allocators and money managers. More than 16,000 portfolio...

McGraw Hill & the Commoditization of Education Resources

This position was closed on August, 18, with a return of 21.47%. Thirteen years after Apollo Global Management, Inc. (APO) took McGraw Hill, Inc. (MH: $17/share) private, the global education solutions provider, raised $415 million in its initial...

Ringkjøbing Landbobank: Priced for Decline, Built for Compounding

Recently, I have found value in banks, specifically, JPMorgan Chase & Co. (JPM), and Lion Finance Group PLC (LON:BGEO), and now, with Danish regional bank, Ringkjøbing Landbobank A/S (CPH:RILBA, 1400 kr.), the subject of this thesis. With a...
Scroll to Top